Baseline predictors of antibiotics de-escalation from empirical therapies in an intensive care unit: a five-year retrospective study

被引:0
|
作者
Arulappen, Ann Lisa [1 ,2 ]
Khan, Amer Hayat [2 ]
Danial, Monica [3 ]
Hasan, Syed Shahzad [4 ]
Chow, Ting Soo [5 ]
Ahmed, Nehad Jaser [6 ]
Long, Chiau Ming [7 ]
机构
[1] Penang Hosp, Minist Hlth, Dept Pharm, George Town, Penang, Malaysia
[2] Univ Sci Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, Georgetown, Malaysia
[3] Seberang Jaya Hosp, Clin Res Ctr, Minist Hlth, Permatang Pauh, Penang, Malaysia
[4] Univ Huddersfield, Sch Appl Sci, Dept Pharm, Huddersfield, England
[5] Penang Hosp, Dept Med, Minist Hlth, Georgetwon, Malaysia
[6] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Al Kharj, Saudi Arabia
[7] Sunway Univ, Sch Med & Life Sci, Sunway City, Selangor, Malaysia
关键词
Antibiotics; De-escalation; Factors; Mortality; Retrospective analysis; INFECTIONS; MORTALITY; IMPACT; OUTCOMES; SEPSIS;
D O I
10.1186/s12879-025-10752-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The alarming rate of bacterial resistance has urged for vigorous antibiotic de-escalation cultures worldwide. However, the art of de-escalation remains challenging as most clinicians have the fear or stigma that antibiotic de-escalation is strongly associated with higher mortality. This study aimed to determine the factors strongly correlated with higher mortality rates after antibiotic de-escalation and possibly serve as a benchmark study for developing a validated antibiotic de-escalation tool in the near future. Method This retrospective study was conducted on patients hospitalized in a medical intensive care unit of a referral tertiary care center and subjected to antibiotics de-escalation over five years. Independent factors associated with mortality post antibiotics de-escalation were assessed. Various data were collected, including patient demographics, admission and discharge dates, a primary source of infection and free of infection status, choices of antibiotic used and de-escalation history, vital signs, data on X-ray changes, relevant laboratory investigations, microbiological culture history, mortality status, history of COVID-19 infection, presence of central line, number of vasopressors used, ventilator settings and respective SOFA scores. Results Prevalence of mortality among patients continued on broad-spectrum antibiotics empirically is remarkable. Through this study, it was found that the significant factors associated with mortality post antibiotic de-escalation were hospital-acquired infection (HAI) (Adjusted OR: 12.56; 95% CI: 2.88,54.98; p < 0.001), systolic blood pressure in mmHg (Adjusted OR: 0.08; 95% CI: 0.02,0.33; p < 0.001), heart rate in bpm (Adjusted OR: 0.12; 95% CI: 0.03,0.45; p:0.002), SOFA scores (Adjusted OR: 21.44; 95% CI: 3.55,129.52; p:0.001) and number of vasopressors (Adjusted OR: 38.46; 95% CI: 1.54,959.30; p:0.026). Conclusion De-escalation of antibiotics is considerable as the identified significant factors serve as baseline predictors which would certainly be helpful especially during the decision-making process of antibiotic de-escalation among the clinicians. Therefore, antibiotics de-escalation is highly encouraged to reduce the mortality risks.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Antibiotic De-escalation in the Intensive Care Unit
    Razazi, K.
    Brun-Buisson, C.
    REANIMATION, 2014, 23 (03): : 278 - 283
  • [2] Sepsis in pediatric intensive care unit - A five-year retrospective
    Puseljic, S.
    Izakovic, S.
    Milas, V.
    Zibar, L.
    Puseljic, I.
    Sipl, M.
    NEUROLOGIA CROATICA, 2006, 55 : 39 - 46
  • [3] ANTIMICROBIAL DE-ESCALATION PRACTICES IN THE INTENSIVE CARE UNIT
    Patanwala, Asad
    Abu Sardaneh, Arwa
    Alffenaar, Jan-Willem
    Dey, Alexandra
    Duffy, Eamon
    Green, Sarah
    Hills, Thomas
    Howle, Lisa
    Joseph, Jessica
    Khuon, Maxkirivan
    Koppen, Cassandra
    Ng, Wing
    Pang, Francis
    Park, Jung Yeun
    Parlicki, Mark
    Shah, Isha
    Tran, Kylie
    Tran, Priscilla
    Xu, Jessica
    Youssef, Marian
    CRITICAL CARE MEDICINE, 2024, 52
  • [4] De-escalation after empirical meropenem treatment in the intensive care unit: Fiction or reality?
    De Waele, Jan J.
    Ravyts, Mariska
    Depuydt, Pieter
    Blot, Stijn I.
    Decruyenaere, Johan
    Vogelaers, Dirk
    JOURNAL OF CRITICAL CARE, 2010, 25 (04) : 641 - 646
  • [5] De-escalation therapy: 1-year experience in a general intensive care unit
    E Gyurov
    S Milanov
    M Georgieva
    M Milanov
    Critical Care, 9 (Suppl 1):
  • [6] De-escalation practice pattern in an Indian intensive care unit
    A Bhakta
    M Bhattacharyya
    S Todi
    Critical Care, 14 (Suppl 1):
  • [7] Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation
    Campion, Maureen
    Scully, Gail
    JOURNAL OF INTENSIVE CARE MEDICINE, 2018, 33 (12) : 647 - 655
  • [8] Antibiotic De-Escalation Practices in the Intensive Care Unit: A Multicenter Observational Study
    Patanwala, Asad E.
    Abu Sardaneh, Arwa
    Alffenaar, Jan-Willem C.
    Choo, Chui Lynn
    Dey, Alexandra L.
    Duffy, Eamon J.
    Green, Sarah E.
    Hills, Thomas E.
    Howle, Lisa M.
    Joseph, Jessica A.
    Khuon, Maxkirivan C.
    Koppen, Cassandra S.
    Pang, Francis
    Park, Jung Yeun
    Parlicki, Mark A.
    Shah, Isha S.
    Tran, Kylie
    Tran, Priscilla
    Wills, Mardi A.
    Xu, Jessica H.
    Youssef, Marian
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (04) : 311 - 318
  • [9] TIME TO BLOOD CULTURE POSITIVITY IN THE INTENSIVE CARE UNIT: IMPLICATIONS FOR DE-ESCALATION
    Sellers, Lindsey
    Forehand, Christy
    Newsome, Andrea
    CRITICAL CARE MEDICINE, 2020, 48
  • [10] Evaluation of the Benefits of De-Escalation for Patients with Sepsis in the Emergency Intensive Care Unit
    Niimura, Takahiro
    Zamami, Yoshito
    Imai, Toru
    Nagao, Kanako
    Kayano, Masafumi
    Sagara, Hidenori
    Goda, Mitsuhiro
    Okada, Naoto
    Chuma, Masayuki
    Takechi, Kenshi
    Imanishi, Masaki
    Koyama, Toshihiro
    Koga, Tadashi
    Nakura, Hironori
    Sendo, Toshiaki
    Ishizawa, Keisuke
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2018, 21 : 54 - 59